Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.
about
Canine cancer immunotherapy studies: linking mouse and human.Recent clinical trials of cancer immunogene therapy in companion animals.CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside.Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.Barking up the right tree: advancing our understanding and treatment of lymphoma with a spontaneous canine model.The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells.Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers.Immunotherapy for Dogs: Running Behind Humans.Engineering chimeric antigen receptor-T cells for cancer treatment.Development of anti-human mesothelin-targeted chimeric antigen receptor (CAR) messenger RNA (mRNA)-transfected peripheral blood lymphocytes (CARMA-hMeso) for ovarian cancer therapy.Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.White paper on microbial anti-cancer therapy and preventionCheckpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas
P2860
Q30239893-FA993182-836C-4849-BAFF-1EA590BD8B93Q33711518-C364E676-048D-4749-8F96-3188DEEA2891Q37559401-9FCED550-135C-442F-AED4-1E8AEF926C11Q37587362-29A4EA89-5CC4-494E-A483-3AF1B8947849Q38371241-23E6AC73-C90C-49D0-AA48-6EC87CEEB9B4Q40095245-EA045ACC-5763-41A3-B7A4-66DB7578793EQ42367177-1F7623E0-2365-4AA9-8C55-A33A6AB46200Q49829334-997706A2-FA10-4115-B877-CD5000D989DFQ49962991-CE113364-591C-428B-A941-8DC0C25E774BQ50025535-A810A18B-2DBB-485F-A830-9866733B4B5EQ55081994-FB9435CA-9CFD-403F-AD4E-2B861F126B9FQ56898750-5221ADDD-82F3-47BC-8235-4C3FBA225102Q57300937-DD466B61-65C0-4FDD-BAFF-1EB483D4584C
P2860
Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Feasibility and Safety of RNA- ...... h Spontaneous B Cell Lymphoma.
@en
type
label
Feasibility and Safety of RNA- ...... h Spontaneous B Cell Lymphoma.
@en
prefLabel
Feasibility and Safety of RNA- ...... h Spontaneous B Cell Lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Feasibility and Safety of RNA- ...... th Spontaneous B Cell Lymphoma
@en
P2093
Colleen M O'Connor
Daniel J Powell
Jenessa B Smith
Josephine Gnanandarajah
Keith Schutsky
Nicola J Mason
P2860
P304
P356
10.1038/MT.2016.146
P577
2016-07-12T00:00:00Z